Thornburg Investment Management Inc. Has $3.65 Million Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Thornburg Investment Management Inc. trimmed its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 7.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 22,904 shares of the company's stock after selling 1,965 shares during the period. Thornburg Investment Management Inc. owned 0.08% of Inspire Medical Systems worth $3,648,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. True Wealth Design LLC boosted its stake in shares of Inspire Medical Systems by 39.0% during the 4th quarter. True Wealth Design LLC now owns 196 shares of the company's stock valued at $36,000 after buying an additional 55 shares during the period. Captrust Financial Advisors boosted its stake in shares of Inspire Medical Systems by 2.0% during the 4th quarter. Captrust Financial Advisors now owns 3,034 shares of the company's stock valued at $562,000 after buying an additional 59 shares during the period. MML Investors Services LLC boosted its stake in shares of Inspire Medical Systems by 0.9% during the 4th quarter. MML Investors Services LLC now owns 7,941 shares of the company's stock valued at $1,472,000 after buying an additional 67 shares during the period. Mariner LLC boosted its stake in shares of Inspire Medical Systems by 1.6% during the 4th quarter. Mariner LLC now owns 4,837 shares of the company's stock valued at $897,000 after buying an additional 77 shares during the period. Finally, Allianz Asset Management GmbH boosted its stake in shares of Inspire Medical Systems by 1.6% during the 1st quarter. Allianz Asset Management GmbH now owns 5,000 shares of the company's stock valued at $796,000 after buying an additional 78 shares during the period. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Wells Fargo & Company decreased their target price on shares of Inspire Medical Systems from $195.00 to $174.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Stifel Nicolaus decreased their target price on shares of Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating for the company in a research note on Monday, April 21st. Royal Bank Of Canada decreased their price objective on shares of Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Robert W. Baird upped their price objective on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the stock an "outperform" rating in a report on Tuesday, May 6th. Finally, Wall Street Zen cut shares of Inspire Medical Systems from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $208.55.

Inspire Medical Systems Trading Up 1.3%

Inspire Medical Systems stock traded up $1.61 on Friday, reaching $126.15. 907,460 shares of the stock were exchanged, compared to its average volume of 545,615. The stock has a market cap of $3.72 billion, a PE ratio of 58.13, a PEG ratio of 2.01 and a beta of 1.25. Inspire Medical Systems, Inc. has a twelve month low of $123.25 and a twelve month high of $225.00. The firm has a fifty day moving average price of $132.12 and a two-hundred day moving average price of $155.22.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.33. The firm had revenue of $201.32 million during the quarter, compared to analyst estimates of $194.89 million. Inspire Medical Systems had a net margin of 7.92% and a return on equity of 10.00%. The business's revenue was up 22.7% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.34) EPS. Equities analysts anticipate that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.